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Oxytocin (OT), the main neuropeptide of sociality, is expressed in neurons exclusively
localized in the hypothalamus. During the last decade, a plethora of neuroendocrine,
metabolic, autonomic and behavioral effects of OT has been reported. In the urgency to
find treatments to syndromes as invalidating as autism, many clinical trials have been
launched in which OT is administered to patients, including adolescents and children.
However, the impact of OT on the developing brain and in particular on the embryonic
and early postnatal maturation of OT neurons, has been only poorly investigated. In the
present review we summarize available (although limited) literature on general features
of ontogenetic transformation of the OT system, including determination, migration and
differentiation of OT neurons. Next, we discuss trajectories of OT receptors (OTR) in the
perinatal period. Furthermore, we provide evidence that early alterations, from birth, in the
central OT system lead to severe neurodevelopmental diseases such as feeding deficit in
infancy and severe defects in social behavior in adulthood, as described in Prader-Willi
syndrome (PWS). Our review intends to propose a hypothesis about developmental
dynamics of central OT pathways, which are essential for survival right after birth and
for the acquisition of social skills later on. A better understanding of the embryonic and
early postnatal maturation of the OT system may lead to better OT-based treatments in
PWS or autism.
Keywords: oxytocin, oxytocin receptor, ontogenesis, somatodendritic release, axonal release, autisn, Prader-Willi
syndrome
INTRODUCTION
Oxytocin (OT) is a neuropeptide which is synthesized in defined
nuclei of the hypothalamus, paraventricular (PVN), supraop-
tic (SON), and accessory (AN) nuclei and secreted both in the
blood circulation as a hormone and in the brain as a neuro-
modulator. During the last decade, hundreds of original reports
and reviews have been published, clearly showing that the OT
system is a key regulator of all the aspects of social behavior,
including those involved in reproduction and care of the offspring
(Lee et al., 2009). Notably, in humans, OT facilitates the pro-
cessing of social information and improves cognitive emphatic
abilities, representing a potential new approach for the treatment
of autism spectrum disorders, as extensively reviewed elsewhere
(Meyer-Lindenberg et al., 2011). Even if OT is currently regarded
as a “prosocial” drug, this does not implicate per se a “positive”
connotation. OT has been found to increase trust and generosity
(Kosfeld et al., 2005), but also gloating and envy (Shamay-Tsoory
et al., 2009), which are also manifestations of complex “social”
behaviors. Similarly, OT increases in-group but not out-group
cooperation, an ethnocentric behavior that can promote preju-
dice, xenophobia, and intergroup violence (De Dreu et al., 2011).
Furthermore, OT has been found to induce adverse behavior in
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borderline-personality disorders (Bartz et al., 2011). These results
suggest that the selection of patients will play a crucial role in
determining the outcome of the symptomatic treatment with
this neuropeptide, the use of which should be restricted to those
individuals who could benefit from it. An understanding of the
OT-mediated cellular and molecular mechanisms on neuronal
networks underlying social and feeding behavior is needed for
a successful employment of this peptide in neuropsychiatric and
genetic disorders. However, despite the large body of knowledge
about physiology and central pathways of OT (see reviews from
Landgraf and Neumann, 2004; Ross and Young, 2009; Lee et al.,
2009; Knobloch and Grinevich, 2014), the developmental aspect
of the OT system remains the “locus minoris” of neuroscience
and neuroendocrinology. Here, we collected virtually all of the
available information, including our personal ongoing research,
and provide some general conclusions regarding the dynamics of
central OT pathways in prenatal and early postnatal ontogenesis.
Furthermore, we clearly demonstrate, by investigating a mouse
model for the Prader-Willi syndrome (PWS), that changes in the
developmental maturation of the OT system cause metabolic and
social alterations. These can be significantly improved or even
fully compensated by OT treatment in the first days after birth,
opening the door for a powerful pharmacological therapy for
PWS in early infancy.
THE BIRTH OF OT-ERGIC NUCLEI
In many species (rodent, human, zebrafish, chicken), all oxytocin
(OT) neurons are generated from the proliferative (“convoluted”)
neuroepithelium of the diamond shaped third ventricle (Table 1
and Figure 1). Birth-dating studies revealed that these hypothala-
mic neurons are generated in the second half of the gestational
period in rodents, within the first quarter of the gestational
period (E30-43; length of pregnancy ∼165 days) in macaques
(Markakis, 2002) and at the middle of pregnancy in humans
(Swaab, 1995).
In rodents, the SON and PVN appear very early. At embry-
onic day (E) 12.5 dpc (days post-coîtum), two groups of cells
are identified in the mouse: one near the third ventricle and the
other moved lateral to the surface pial to give rise to the SON
(Dongen and Nieuwenhuys, 1989). At E14.5 dpc, the PVN and
the SON are settled (Nakai et al., 1995), while AN are recog-
nized later (probably due to their small size and relatively small
number of cells; Altman and Bayer, 1978a,b,c). At this stage,
an antibody recognizing the Neurophysin-I (the carrier protein
for OT) reveals a positive immunosignal (Figure 1B), consistent
with the expression of the OT-prohormone, not yet detected at
E12.5 dpc. Furthermore, an antibody recognizing the intermedi-
ate forms of OT (VA10) reveals a positive immunosignal of the
OT-intermediate forms at E16.5 dpc (Figure 1C), but not at E14.5
dpc. Importantly, the mature, amidated form of OT is detected
at birth (see Table 1) and co-exists with immature forms of OT
during the entire postnatal life (Figure 1D). The role of an earlier
production of the non-mature forms of OT has not been studied,
although a functional role of these forms during the embryonic
development has been suggested (Tribollet et al., 1988).
In humans, the SON and PVN are completely formed at
25 weeks of gestation (Dörner and Staudt, 1972) and OT-
immunoreactivity is first detected at the age of 26 weeks (Wierda
et al., 1991). At that age, the number of stained OT neurons is
relatively similar in the fetal and adult hypothalamus (Van der
Woude et al., 1995), while the morphological analysis of indi-
vidual magnocellular neurons suggests that these cells are still
immature, as can be seen by the gradual increase of their nuclear
volume (Rinne et al., 1962; was also observed in the rat by Crespo
et al., 1988).
GENETIC HIERARCHY OF OT NEURON FORMATION
The signaling molecules and transcription factors that are
involved in the determination and differentiation of OT neurons
are not well known, only a few mouse studies reported factors
Table 1 | Birth of OT neurons and OT synthesis.
Biosynthesis Mouse Rat Primates/Human
Birth of OT neurons E10.5-12.5: postmitotic neurons giving
rise to the PVN, SON, AN (Caqueret
et al., 2006)
E13.5-E15.5: terminal differentiation of
PVN and SON neurons (Caqueret et al.,
2006)
E13-E15 for the PVN
E13-E14 for the SON (Altman and
Bayer, 1978a,b,c)
In macaques:
E30-E38 for the PVN
E40-E43 for the SON (van
Eerdenburg and Rakic, 1994)
Initial OT gene
expression (based on
in situ hybridization)
E15.5
E15.5 (presumptive PVN) and E18.5
(SON) (Allan Brain Atlas, Jing et al., 1998)
E16-E17 (SON, PVN) (Laurent et al.,
1989; Trembleau et al., 1995)
15 Weeks of human
gestation (Allan Brain Atlas)
Initial synthesis of
pre-proOT (based on
immunohistochemistry)
E14.5
PVN, SON, AN (Figure 1 of this review)
E16 (PVN, SON) (Whitnall et al., 1985;
Altstein and Gainer, 1988)
ND
Initial production of
mature form of OT
P0 (birth) in PVN, SON, AN (Schaller
et al., 2010)
E21-P0 (SON, PVN, AN) (Boer et al.,
1980; Buijs et al., 1980; Sinding et al.,
1980; Whitnall et al., 1985; Altstein
and Gainer, 1988)
14 Weeks of gestation
(Schubert et al., 1981;
Goudsmit et al., 1992; Swaab
et al., 1995)
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FIGURE 1 | Ontogenesis of the OT neurons during mouse embryonic
development. (A) The developmental stages and transcription factors (in red
in the drawings) known to be involved in the setting of the PVN, SON, and
AN. Below are indicated several genes known to be expressed in OT neurons
and the inactivation of each of these genes alters OT neurons. The
developmental stages from which an expression of OT transcript, OT
prohormone and OT-mature form are detected are also indicated (in black).
(B) Immunohistochemical detection of the OT-neurophysin I (associated with
OT prohormone) using the PS38 antibody (in red) and of the OT-intermediate
forms using the VA10 antibody (in green). At E12.5 pcd, we did not detect any
signal (not shown). At E14.5 pcd we first detect few cells expressing the
OT-neurophysin I (B), probably the OT-prohormone, but not OT intermediate
forms. (C) At E16.5 pcd we detect both OT-neurophysin I and the OT
intermediate forms. (D) At the day of birth virtually all OT neurons of the PVN
co-express both OT-neurophysin I and immature forms of OT. White arrows
indicate the location of the third ventricle.
involved in the early stages of development of the hypothalamic-
neurohypophyseal system (Carrel and Allen, 2000; Caqueret et al.,
2006; Szarek et al., 2010).
The early patterning of hypothalamus has been shown to
depend on a cascade of transcription factors (Figure 1A): firstly
the sonic hedgehog (SHH) is necessary to establish the hypotha-
lamus primordium (E9.5 dpc in mouse) (Mathieu et al., 2002;
see also Blaess et al. (2014) in this Research Topic of Frontiers
in Neuroanatomy); the local production of the bone morpho-
genetic proteins (BMPs) is then required to down-regulate SHH
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and establish region specific transcription profiles (Ohyama et al.,
2008). The bHLH-PAS (basic helix-loop-helix PER-ART-SIM)
transcription factor SIM1 is expressed in the incipient PVN,
SON and AN from E10.5 dpc (Caqueret et al., 2006) where
it dimerises with ARNT2 (Michaud et al., 2000; Hosoya et al.,
2001). A key downstream target of SIM1/ARNT2 is Brn2, a
POU domain transcription factor required for OT (as well
as for two other types of neuroendocrine neurons, expressing
arginine-vasopressin (AVP) and corticotropin releasing hormone
neurons of the PVN/SON/AN and expressed from E11.5 dpc,
Nakai et al., 1995; Schoneman et al., 1995). In a parallel or con-
vergent SIM1/ARNT2 pathway, the homeobox orthopedia (OTP)
factor is also necessary for Brn2 expression (Caqueret et al.,
2006), which is still expressed at E15.5 dpc, with Nkx2.2. All of
these factors are required to define at E12.5 dpc the prospec-
tive PVN domain, however, from this stage on, the factors that
will specify the parvocellular1 and magnocellular OT neurons
have not been identified. The ablation of Brn2 results in a loss
of all neurons of the PVN, SON and presumably of the AN
(Nakai et al., 1995; Schoneman et al., 1995). Importantly the
lack of axonal projections of magnocellular OT and AVP neu-
rons in the Brn2 knock-out mice to the pituitary (Schoneman
et al., 1995), as also observed in the Arnt2-knockout mice
(Hosoya et al., 2001), leads to progressive loss of pituicytes
(pituitary astrocyte-like glial cells). All together, these results
suggest a role of OT and/or AVP in the formation of the neu-
rohypophysis. Indeed, in the absence of OT, the neurovascular
interface in the neurohypophysis does not form in zebra fish
(Gutnick et al., 2011).
One approach to identify such factors involved in the deter-
mination and differentiation of OT cells is the analysis of the
OT promoter and its upstream and downstream sequences.
Interestingly, genomic DNA constructs, including more than
500 base pairs (bp) upstream and 3.6 kb downstream of the
OT gene, enabled an expression of OT or EGFP-reporter in
OT-neurons only (Young et al., 1990; Belenky et al., 1992)
in adult transgenic rodents. Later, a genomic analysis of the
OT-promoter (500 bp) defined a minimal promoter sufficient
for expression in OT-neurons (magnocellular neurons) of adult
rodents (Fields et al., 2012; Gainer, 2012). Several binding sites
for transcription factors (ERE, COUP-TF, SF1) have been identi-
fied in this sequence, but not the ones for the transcription factors
described above (Figure 1A), suggesting that the DNA sequence
required for the development of OT cells is not present in these
500 bp.
In conclusion, from the E12.5 dpc stage, the transcriptional
factors that will specify the parvocellular and magnocellular OT
neurons have not yet been characterized.
Several other genes such as fibroblast growth factor 8 (Brooks
et al., 2010), the Mage-D1, Necdin and Magel2 genes, CD38, Peg3
(Figure 1 and Table 3), are known to be expressed in mouse
hypothalamus during development. Their knock-out (KO) alters
1Parvocellular OT neurons belong to a relatively small population of PVN
cells, which project to the brainstem and spinal cord (Sawchenko and
Swanson, 1982) and control appetite, nociception and autonomic functions.
The development of these particular neurons has not been studied.
the number and/or function of OT-neurons, but their role in
OT-neurons is not clarified yet.
THE BIOSYNTHESIS OF OT IN ONTOGENESIS
In the rat and mouse, the OT can be detected by several
techniques (such as radioimmunoassay, enzyme immunoassay,
immunohistochemistry) from the beginning of the second gesta-
tional week (Table 1). However, all of these techniques are based
on the use of OT antibodies. The specificity of these antibodies,
in particular against the different forms of OT, is not always
established. The most reliable and relevant studies have been
performed with the use of antibodies characterized by Harold
Gainer’s laboratory or using Mass Spectrometry Ànalysis, which,
unfortunately, has not been used in developmental studies. Based
on the tools used for OT detection, the OT prohormone is
found in embryos just after the appearance of the OT mRNA,
while the mature OT peptide is only released from birth on
(Table 1 and Figure 1). The OT gene encodes for the Pre-Pro-OT-
Neurophysin I (pre-pro-hormone), which is cleaved by different
enzymes to give rise to different OT intermediate forms and to
the Neurophysin I, and finally to the mature amidated form that
is released (Figure 2). It has been shown that the steady state
of the mature OT form can be controlled by an oxytocinase
(P-LAP) that is produced in periphery and centrally by the OT-
magnocellular neurons. Noticeably, P-LAP is also expressed in
parvocellular OT neurons and in other brain structures (Tobin
et al., 2014).
Before birth, there is a delay in OT prohormone process-
ing with an accumulation of the OT intermediate forms in OT
neurons until birth. This delay was not observed for AVP process-
ing as the amidated AVP form is detected as early as E16.5 dpc
(Whitnall et al., 1985; Altstein and Gainer, 1988). Furthermore,
morphological and electrophysiological properties of the magno-
cellular OT neurons are not mature at birth; their morphological
and electrophysiological properties develop progressively during
the first two postnatal weeks (see below, as well as Swaab, 1995,
1997a,b). Thus, although functional at birth, the OT-ergic sys-
tem undergoes a progressive maturation during early postnatal
life and is not mature before weaning in rodents and, most likely,
in human infants as well. However, a comparison of immature
and mature forms of OT in human development has never been
studied.
ELECTRICAL PROPERTIES OF OT NEURONS AFTER BIRTH
To our knowledge, no electrophysiological studies have been
performed on embryonic OT neurons. However, the groups
of Francoise Moos and Michel G. Desarmenien systematically
analyzed electrical activity of magnocellular neurons (although
without distinction between OT and AVP) in the SON of rats
during early postnatal life. Three main features arise from these
studies: the importance of the second postnatal week (PW2),
the role of autocontrol by OT, presumably released from soma
and dendrites, and the determinant role of the development of
electrophysiological features on the morphological maturation of
the neurons. At birth and during PW1, the membrane potential
is unstable and cells fire small and large erratic action poten-
tials. During PW2, the membrane potential stabilizes to a more
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FIGURE 2 | Starting from the gene: the biosynthesis of the different
forms of OT. This scheme represents the genomic structure of the OT gene,
which is contiguous to the AVP-gene; regulatory elements might be shared.
The transcription and translation steps of the OT gene are then indicated.
First, OT preprohormone is produced, that will be cleaved and matured by
successive enzymes. The OT intermediate forms are produced from E16.5
(see above) but the mature amidated OT form is detected only from birth.
The released mature form is then degraded by an oxytocinase (PLAP) or
binds to OT binding sites (OTR or V1a-receptors). PAM, alpha-amidating
monooxygenase; PLAP, placental leucine aminopeptidase.
hyperpolarized value, the spontaneous activity becomes orga-
nized and the action potential progressively increases in size and
decreases in duration, leading to a decrease in action potential-
evoked calcium entry (Widmer et al., 1997; Chevaleyre et al.,
2000). At the end of PW2 and during PW3, a switch in regula-
tion of intracellular free calcium from extrusion to sequestration
into the reticulum also occurs (Lee et al., 2007a). These two mod-
ifications of calcium entry and regulation may have important
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consequences on peptide secretion. The PW2 is also the period
during which the chloride equilibrium potential becomes hyper-
polarized, GABA becomes inhibitory and glutamatergic activity
appears (Chevaleyre et al., 2001), together with an increase in
NMDA receptor expression (Hussy et al., 1997). Most interest-
ingly, this period of action potential and synaptic activity matu-
ration is concomitant with the appearance of a major feature of
SON neurons: autocontrol (Figure 3).
OTRhasbeenshowntoplayan important role inautoregulation
of magnocellular neuronal activity (Richard et al., 1997) and it
is well established that OTRs are expressed in adult PVN (van
Leeuwen et al., 1985; Freund-Mercier et al., 1987; Tribollet et al.,
1988;Yoshimuraetal.,1993;Adanetal.,1995).Duringontogenesis,
cells expressing OTRmRNAhave been observed in SON and PVN
starting fromP1 (Yoshimura et al., 1996), a finding consistent with
the faint and diffuse expression of OTR present throughout the
hypothalamus at this stage (Tribollet et al., 1989). An increase in
OTRmRNAexpression is detected fromP7 and is thenmaintained
fairly stably to adulthood (Yoshimura et al., 1996).
Consistently with changes in OTR expression during PW2, OT
and its related analog are most efficient in increasing electrical
activity on one-third of SON neurons (supposed to be OT-ergic
neurons since they were insensitive to AVP) and somatodendritic
release of native OT (Chevaleyre et al., 2000).
The somatodendritic release of OT not only activates action
potential firing, it is also determinant for the maturation of glu-
tamatergic synaptic activity and of the neuronal morphology.
Indeed at birth, supraoptic neurons display an oblong soma from
which 2-3 dendrites with few proximal branches arise (Chevaleyre
et al., 2001). However, during PW2, the interplay between incom-
ing glutamatergic inputs and autocontrol induces an intense
sprouting of dendritic branches (Chevaleyre et al., 2002), as if
neurons were exploring the environment to establish new con-
nections. This sprouting is transient and the neurons acquire
their mature morphology (Randle et al., 1986) by the end of
PW2. Although partial and concerning only SON OT neurons,
these data point to a determinant role of autocontrol of OT
neurons during PW2 in rats. This information should be taken
into account in our understanding of how OT treatments dur-
ing infancy can have lifelong consequences on OT-related social
diseases (see the chapter below).
ESTABLISHMENT OF OT CIRCUITRY
Since neuroendocrinology was established as a new discipline,
it has been clearly demonstrated that magnocellular (both OT
and AVP) neurons of adult vertebrate species, including mam-
mals, are primarily projecting to the posterior pituitary lobe to
release these hormones into the systemic blood stream (Knobloch
and Grinevich, 2014 and references therein). However, embryo-
genesis of pituitary OT projections remains unexplored. In fact,
only two studies demonstrate such projection in rats without
discrimination between OT and AVP components. The first
study by the Ann-Judith Silverman group (Silverman et al.,
1980) showed the existence of neurophysin-positive (i.e. without
FIGURE 3 | “Auto-control” of OT neurons in early postnatal ontogenesis.
In the rat SON during the second PN week, locally released OT promotes
calcium mobilization and OT release, and favors the maturation of
glutamatergic inputs. Activation of NMDA and OTR increases electrical
activity and mobilization of calcium from intracellular stores and promotes
growth of new dendritic branches.
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discrimination between OT and AVP) fibers in the posterior
pituitary. Another study by the Michael Ugrumov and André
Calas groups (Makarenko et al., 2000, 2002), employing DiI-
based retrograde tracing in fixed brains, showed certain dynamics
of these projections: first connections between the main part
of the SON and pituitary are established earlier (detected at
E15—earliest time point of the experiment), while the PVN and
retrochiasmatic parts of the SON project to the pituitary later—
at E17 (Makarenko et al., 2000). Intriguingly, the AN, composed
mostly of OT neurons, projects to the pituitary only after birth
(Makarenko et al., 2002).
Remarkable work on zebra fish larvae showed that OT is essen-
tial for the formation of an effective neurovascular interface (i.e.,
contacts of axonal OT terminals with fenestrated capillaries in
the posterior pituitary; Gutnick et al., 2011). Unfortunately, such
observation has not been extended to mice lacking OT or OTR,
in which the analysis of the pituitary structure has not been
reported.
Although central projections of OT neurons in adult rodents
(mice, rats, and voles) have been significantly explored during last
years (Ross et al., 2009; Knobloch et al., 2012; Dölen et al., 2013),
the literature lacks reports on embryogenesis and early postna-
tal development of OT projections. This concerns both ascending
projections of magnocellular OT neurons to the forebrain and
descending projections of parvocellular OT neurons terminating
in the brain stem and spinal cord.
The major inputs carrying visceral sensory information to
the SON and PVN are relayed by catecholaminergic and non-
catecholaminergic (glucagon-like peptide 1) neurons whose soma
are located in the nucleus of the solitary tract and ventrolat-
eral medulla. Both direct and indirect arguments indicate that
these afferents are not functional at birth and develop during
the first postnatal week (see review by Rinaman, 2007). Similarly,
although no anatomical studies on the dynamics of innervation
of OT neurons by glutamate and GABA have been performed,
electrophysiological data summarized above suggest long-term
postnatal maturation of synaptic inputs.
THE DEVELOPMENTAL TRAJECTORIES OF OT RECEPTOR
EXPRESSION
The developmental trajectories of OT receptor (OTR) expres-
sion in the nervous system have been investigated in mice, rats,
voles and humans by different experimental approaches such as
autoradiography, in situ hybridization and transcriptomic analy-
sis, which provide complementary information.While autoradio-
graphy maps high affinity OTR at subcellular sites, which grossly
correspond to receptor site(s) of activity on neuronal cell bod-
ies and processes, in situ hybridization maps the neuronal bodies
in which OTR mRNA accumulates. Transcriptomic analysis pro-
vides clues on brain regions actively synthesizing OTR mRNA
without giving details on the cell types and subpopulations
involved (see Table 2 for the available literature).
Among mammalian species, the rat has been by far the most
extensively investigated. In this animal, the three aforementioned
techniques resulted in highly comparable and consistent results,
whichmade it possible to trace a developmental trajectory of OTR
ontogenesis. This has been schematically summarized in Table 3
and Figure 4 (Shapiro and Insel, 1989; Snijdewint et al., 1989;
Table 2 | Studies of OTR trajectories in development.
Mice Rats Voles Human
Method: autoradiography (125I-OTA)
Age: E18.5, P0, PN7, PN14, PN21,
PN35, PN60
Subject: all embryos and brain
(Hammock and Levitt, 2013)
Method: transcriptomic analysis
Age: PN4, PN6, PN8, PN10, PN14,
P180
Subject: primary somatosensory
cortex (Fertuzinhos et al., 2014;
http://hbatlas.org/
mouseNCXtranscriptome/)
Method: autoradiography (125I-OTA)
Age: PN1, PN5, PN10, PN14, PN18,
PN24, PN60
Subject: brain (Shapiro and Insel, 1989)
Method: autoradiography (125I-OTA)
Age: E12, E14, E16, E18, E20, PN1, PN3,
PN5, PN10, PN13, PN16, PN19, PN22,
PN25, PN30, PN35, PN40, PN45, PN60,
PN90
Subject: brain and spinal cord (Tribollet
et al., 1989)
Method: autoradiography (125I-OTA)
Age: E12, E14, E16, E18, E20, PN1, PN3,
PN5, PN10, PN13, PN16, PN19, PN22,
PN25, PN30, PN35, PN40, PN45, PN60,
PN90
Subject: forebrain (Lukas et al., 2010)
Method: autoradiography (3H-OT)
Age: E20, PN1, PN5, PN15
Subject: brain (Snijdewint et al., 1989)
Method: In situ hybridization
Age: E9, E13, E14, E15, E17, E20, PN1,
PN3, PN7, PN13, PN14, PN22, PN50
Subject: brain and spinal cord (Yoshimura
et al., 1996)
Method: autoradiography
(125I-OTA)
Age: PN1, 1 week, 2 weeks, 3
weeks, 3 months
Subject: lateral septum (Wang
and Young, 1997)
Method: autoradiography
(125I-OTA)
Age: PN6, PN9, PN12, PN15,
PN18, PN21, PN60
Subject: forebrain (Prounis and
Ophir, 2013)
Method: transcriptomic
analysis
Age: 15 different periods of
life from early embryonic
(10-13PCW) to late adulthood
(60Y+) Subject:
Cerebellar cortex,
mediodorsal nucleus of the
thalamus, striatum, amygdala,
hippocampus and 11 areas of
neocortex (Kang et al., 2011)
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Table 3 | Brain structures expressing OTR in different periods of
prenatal and early postnatal life in rats.
Expression pattern Structure
Appearance in prenatal and/or
early postnatal life and
permanence to adult life
Dorsal nucleus of the vagus nerve
Anterior olfactory nucleus
Amygdaloid complex
Nucleus accumbens◦
Dorsal peduncular cortex
Lateral septum
CA1 subfield of the hippocampus
Ventral tegmental area
Bed nucleus of the stria
terminalis*
Hypothalamic ventromedial
nucleus*
Ventral subiculum
Transient expression in prenatal
and/or early postnatal life
Parietal cortex
Cingulate cortex
Retrosplenial cerebral cortex
Mammillary complex
Dorsal subiculum
Caudate putamen
Anterior and paraventricular
thalamic nuclei
Reticular nucleus
Substantia gelatinosa of the V
nerve
Nucleus of the hypoglossus
Expression in late postnatal life Olfactory tuberculum (Calleja
islands)
Ventral pallidum
◦In the adult, binding in the accumbens has been reported to almost completely
disappear (Tribollet et al., 1989) or to be greatly reduced as compared to its pick
at PN20 (Shapiro and Insel, 1989).
*The appearance of OTR in the hypothalamic ventromedial nucleus has been
reported to appear at PN1 (Tribollet et al., 1989) or to emerge only in the adult
brain (Shapiro and Insel, 1989).
Tribollet et al., 1989; Yoshimura et al., 1996; Lukas et al., 2010;
Workman et al., 2013). Throughout the embryonic development
and the first post-natal days, OTR progressively appears in sev-
eral brain regions, reaching a well-defined “infant” pattern of
distribution around PN10. After PN13, an abrupt decline of
OTR density is observed in several areas, accompanied by expres-
sion in novel brain regions; this phase has been referred to as
the first transition to the adult pattern and is basically com-
pleted at PN18. Around and after weaning, a second transition
occurs, characterized by a novel reshaping of OTR expression,
which slowly disappears from some areas and increases in oth-
ers. Finally, the adult pattern of OTR expression is achieved at
P60-90. Brain structures expressing OTR in different periods of
prenatal and early postnatal life in rats (according to Shapiro and
Insel, 1989; Tribollet et al., 1989; Lukas et al., 2010) are reported in
Table 3.
OTR appears as early as E14 pcd is the posterior portion of
the neuronal tube that will become the vagal motor nucleus. Even
though the mature OT is not detected until much later in devel-
opment (see above), immature C-terminal extended forms of OT
have been visualized much earlier (E16 pcd, see above). It is thus
tempting to speculate that some immature OT forms may have
an unrecognized role during early development in the vagal sub-
region. Mechanistically, the delivery of immature OT to the vagal
nucleus can be achieved either via the neuropeptide diffusion
through the brain tissue after somatodendritic release or via the
transventricular pathway (Knobloch and Grinevich, 2014).
Strongly labeled areas of the “infant pattern” around PN10,
schematically reported in Figure 4B, include the anterior olfac-
tory nucleus, caudate putamen, accumbens, cingulate cortex,
bed nucleus of the stria terminalis, some septal, thalamic and
amygdaloid nuclei and the dorsal peduncular cortex. A faint but
specific signal is observed at this stage in the hypothalamic ven-
tral medial nucleus, a region that will become strongly labeled
in the adult brain, while binding in the lateral septum and bed
nucleus of the stria terminalis will undergo an intra-regional
reshaping during post-natal development. Of relevance, between
PN10 and PN25, is the disappearance of binding in the dor-
sal subiculum, accompanied by the concomitant appearance of
increasingly strong binding in the ventral subiculum. During the
same period, binding drops in the thalamus, cingulate cortex and
CA1 but increases sharply in the accumbens, where it peaks at
PN20 to subsequently decline during the second phase of transi-
tion to the adult brain. Changes in selected brain regions between
week 5 and week 8 have been reported, such as an increase in OTR
binding in the ventromedial hypothalamus and a decrease in the
lateral septum (Lukas et al., 2010). However, a detailed, compre-
hensive study of OTR expression trajectories around weaning in
males and females is, at present, missing.
Unfortunately, the studies available in literature for mice, voles
and humans do not allow for similar comprehensive compilation
of OTR expression trajectories during development. Nevertheless,
a recent autoradiography study in mice revealed that region-
specific trajectories of OTR expression are present in this species
as well (Hammock and Levitt, 2013). A qualitative inspection
of OTR binding from P0 to PN60 outlined a progressive strong
increase of OTR from P0 to PN14, followed by region-specific up
and down regulation of receptor expression. Different temporal
expression profiles were reported in the three areas of the brain
in which the OTR binding profile was quantified (hippocam-
pus, lateral septum, and neocortex) with no significant differences
between sexes. A very high degree of individual variability in OTR
expression during ontogenesis was also reported in prairie voles,
hampering the detailed delineation of developmental trajectories
in this species; however, as observed in mice and rats, a higher
density of OTR was observed in some forebrain regions (the
septo-hippocampal nucleus and the hippocampus) between PN6
and PN21 as compared to PN1 and PN60 (Prounis and Ophir,
2013). Similarly, in the lateral septum, OTR density increased
during the post-natal age, reaching the adult level at weaning;
in particular, the binding increased more rapidly in mountain
than in prairie voles, resulting in species differences at weaning
and adulthood (Wang and Young, 1997). Finally, it is worth not-
ing that in the different species, the overall pattern of the OTR
expression during development does not match completely. The
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FIGURE 4 | Developmental trajectories of OTR in the rat brain.
(A) Schematic time course of OTR expression in the developing brain.
(B) OTR expression in the infant brain around P10–P13. Regions in
which a transient OTR expression is observed are colored in yellow;
regions in which OTR expression is maintained to adult life are colored
in magenta.
strong transient expression of OTR in the neocortex reported in
mice was suggested to account for a species-specific role played
by OTR during brain development (Hammock and Levitt, 2013).
However, it should be mentioned that a transient OTR expres-
sion in the parietal cortex has also been reported in the rat brain
(Snijdewint et al., 1989).
As in humans, the transcriptomic analysis of OTR reported
a progressive increase in OTR mRNA during embryonic life in
five out of six brain areas analyzed (Kang et al., 2011 and http://
hbatlas.org/). Remarkably, the receptor level appeared to reach a
maximum already before birth and to remain quite stable there-
after, at least in the first 5 years of life, although with some wide
individual variations.
An important consideration when comparing developmen-
tal trajectories in translational medicine approaches is that the
neurodevelopmental stage of the human brain at birth corre-
sponds to rat and mouse brain at PN10 (Workman et al., 2013
and related web tool at http://www.translatingtime.net/home).
Consistently, the human infant pattern of OTR expression is
achieved before parturition while, in the rat, the infant pat-
tern of OTR expression is achieved around PN10, and, in mice,
between PN7 and PN14. To extrapolate the effects of phar-
macological and environmental manipulation of the OT/OTR
system in the human newborn brain from experiments per-
formed in mice and rats, treatments should thus be performed
in rodents around PN10, when a comparable maturation of
the brain and of the OTR system has been reached in these
species.
Several environmental factors have been reported to affect
OTR expression in embryogenesis and early postnatal life, among
which a predominant role is played by social and sensorial expe-
riences, as more extensively discussed in the next paragraph.
Furthermore, exposure to drugs and toxic agents can also mod-
ulate the OT/OTR system, as outlined by the interesting find-
ing that nicotine and ethanol administration to pregnant rats
increases OTR binding in the nucleus accumbens and in the
CA3 region of the hippocampus of male offspring (Williams
et al., 2009). Recently, an up-regulation of OTR in the nucleus
accumbens, medial anterior olfactory nucleus and central and
medial nuclei of amygdala has been reported inµ-opioid receptor
knock out mice (Gigliucii et al., 2014), which suggests a close link
between OTR expression and the opioid reward system.
OT AND SOCIAL EXPERIENCE IN DEVELOPMENT
Effects of OT during embryogenesis and early postnatal ontoge-
nesis on social life are extensively summarized in recent reviews
(Carter, 2014; Hammock, 2014), but the reverse—i.e., the effects
of social stimuli on maturation of OT system—are less explored.
It has been reported that early social experience tremendously
affects physiology of the OT system (Bales and Perkeybile, 2012;
Hammock, 2014). Recently it has been demonstrated that early
sensory experience (in the newborn) regulates development of
sensory cortices via OT-signaling (Zheng et al., 2014).
This oxytocin early regulation may have long-term conse-
quences in adults. It has been known for many years that exoge-
nous OT in neonates can revert the long-term behavioral effects
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of prenatal stress (Lee et al., 2007b) and has consequences on
other endocrine systems (i.e., the estrogen receptor, Pournajafi-
Nazarloo et al., 2007) as well as on blood pressure (Holst et al.,
2002) in adults. The effects of OT, or of the environmental
and familial circumstances resulting in increased production of
mature neonatal OT, on adult social behavior mainly remain to
be investigated. With respect to OTR expression, increased levels
have been observed in offspring after communal rearing (Curley
et al., 2012), increased maternal licking/grooming (Champagne
et al., 2001) and social enrichment (Champagne and Meaney,
2007). On the contrary, late weaning has been reported to reduce
OTR density in selected, socially relevant, brain regions (Curley
et al., 2009). Furthermore, maternal separation has been found
to induce a complex modulation of OTR expression with region-
specific up and down regulation of OTR (Lukas et al., 2010). It
is important to note, at the end of this section, that exploration
of early life experience on OT/OTR system in animals provides a
scientific basis for child care and new therapeutical approaches
to ameliorating social alterations occurring in adult patients
afflicted with Autism Spectrum Disorders or the PWS (see
below).
OT AND DEVELOPMENTAL NEUROLOGICAL DISORDERS
Many reviews are exhaustive on the involvement of OT in shap-
ing and regulating the social brain (Meyer-Lindenberg et al., 2011;
Striepens et al., 2011; McCall and Singer, 2012) or in learning
and memory (Chini et al., 2014). The strongest line of demon-
stration of the OT system in social behavior, feeding behavior
and maternal care is via the study of knockout mice in which
either the OT or the OTR genes are inactivated (Table 4). Mice
constitutively lacking OT (Oxt−/−) are unable to release milk
and have impaired social memory (Ferguson et al., 2000). Mice
with constitutive ablation of the OTR gene (Oxtr−/−) display
a behavior very similar to the Oxt−/− mouse, mainly marked
by social deficits (Takayanagi et al., 2005). In addition, although
learning is normal in Oxtr-/- mice, reversal learning is strongly
decreased, indicating impaired cognitive flexibility reminiscent of
the ASD syndrome (Sala et al., 2011). Importantly, even a 50%
loss of the OTRs also leads to an impairment of social behav-
ior, suggesting that a fine tuning of the OT system is necessary
to control behavior (Sala et al., 2013). Other mouse models, in
which the knock-out of a specific gene induced a disruption in
the OT system that has been linked to a pathological pheno-
type, reinforce the role of OT in neurodevelopmental disorders
(Table 4). Recently, it has been shown that disruption of the
neonatal surge of OT coming from the mother during delivery
results in autistic-like features in the adults (Tyzio et al., 2014). All
these data suggest that an early postnatal injury or dysfunction
of the OT system has consequences in infant and adult behav-
iors. Unfortunately, the contribution of early life experience to
OT signaling, in a pathological context or following a trauma, has
not been extensively studied in the brain of highly social mam-
malian species such as voles or monkeys. A limited number of
reports (Bales et al., 2007, 2011; Ahern and Young, 2009) demon-
strated that social deprivation and enrichment paradigms induce
changes in OT synthesis and OTR binding in voles (Bales et al.,
2007, 2011; Ahern and Young, 2009). While it is not yet clear how
these changes occur, the most likely scenario is the environmental
influence on the gene expression through epigenetic mechanisms.
In humans, autistic spectrum disorder (ASD) is a broadly-
defined disorder that mainly affects behavior and cognition.
Social interaction impairments are the most characteristic deficits
in ASD. Interestingly, several lines of evidence suggest a role of OT
in the etiology of ASD (Harony and Wagner, 2010; LoParo and
Table 4 | OT and neurodevelopmental disorders.
Alteration Mouse models Human (early neurodevelopmental
disorders)
Feeding problems:
Early impairment of feeding (suckling activity)
Obesity
Magel2 KO (Schaller et al., 2010)
Oxt-KO (Camerino, 2009)
Oxt-KO (Takayanagi et al., 2008)
Sim1-KO (heterozygotes) (Kublaoui et al., 2008)
Prader-Willi syndrome (McAllister et al.,
2011; Miller et al., 2011)
Autistic patients with MAGEL2 mutations
(Schaaf et al., 2013)
Social and emotional defects ASD Oxtr -KO (Takayanagi et al., 2005; Sala et al., 2011, 2013)
Oxt-KO (Ferguson et al., 2000)
CD38-KO (Jin et al., 2007)
BTBR T+ tf/J (Silverman et al., 2010)
Magel2 KO (FM, submitted)
FraX KO (Mineur et al., 2006; Pietropaolo et al., 2011;
Francis et al., 2014)
MageD1-KO (Dombret et al., 2012)
Haploinsufficient reeler (Liu et al., 2005)
ASD (Li et al., 2012; Aoki et al., 2014;
LoParo and Waldman, 2014)
Prader-Willi syndrome (Swaab et al., 1995;
Dykens et al., 2011; Tauber et al., 2011)
Williams syndrome (Dai et al., 2012;
Jarvinen and Bellugi, 2013)
Autistic patients with MAGEL2 mutations
(Schaaf et al., 2013)
Maternal care and/or social development of
the progeny
Oxt-KO (Winslow et al., 2000)
CD38-KO (Liu et al., 2008)
Oxtr -KO (Higashida et al., 2010; Rilling and Young, 2014)
Peg3-KO (Champagne et al., 2009)
OTR risk allele
CD38 risk allele (Feldman et al., 2012;
Rilling and Young, 2014)
Neurodegenerative diseases CD157(BST1) KO Lopatina et al., 2014 No clear data
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FIGURE 5 | Prader-Willi syndrome: clinical features and effects of OT.
(A) Three-month-old baby born at term has symptoms of hypotonia, deficit
of suckling and poor interest in food. Nasogastric tube, which is shown in
the photo, is used in almost all PWS neonates to prevent failure to thrive
for a mean of 1 month. Baby also exhibits facial dysmorphism, such as
almond-shaped eyes, thin upper lip, down-turned corner of the mouth,
narrow bi-frontal diameter and slight facial assymetria. Behaviorally, the
baby shows low interest in mother and poor social skills in general.
Ongoing treatment with OT shows positive trends in both stimulation of
food intake and social bonding with the mother (further confirmation is
needed). (B) Twenty-three-year-old male patient has a record of
hyperphagia, deficit of satiety, obsession with food, dysmorphic features
(scoliosis, kyphosis), autistic-like features (stereotype and repetitive
movements, deficit of social skills and poor trust in others), anxiety,
emotional liability (including emotional outbreaks), creation of stories filled
with fantasies (termed as “fabulation”) and compulsive skin picking. The
patient is under psychotropic treatments. First applications of OT seem to
result in increase of trust, decrease in anxiety and attenuation of emotional
outbreaks (further confirmation is needed). Photos are reproduced here
with permission of Prof. Maithé Tauber.
Waldman, 2014) and OT’s therapeutic effects have been observed
in social communication (Aoki et al., 2014), however, they are still
debated (Guastella et al., 2014). Furthermore, it is also acknowl-
edged that an alteration in the OT-system might be involved in
neurodevelopmental disorders marked by social cue deficits such
as Fragile X Syndrome, Williams Syndrome and PWS (see Table 3
and Francis et al., 2014).
PWS is one of the best reported examples of a neurodevelop-
mental disease characterized mainly as an eating disorder with
behavioral and social disturbances (Figure 5; Butler et al., 2011;
Dykens et al., 2011; McAllister et al., 2011; Cassidy et al., 2012;
Jauregi et al., 2013). PWS is a rare genetic disease with an esti-
mated prevalence worldwide of 1 in 10,000–30,000 individuals
(Cassidy et al., 2012). Patients with PWS exhibit a complex and
progressive phenotype. Their eating behavior is mainly character-
ized by two opposite stages (Butler et al., 2010; Miller et al., 2011).
During phase I of the syndrome, apparent at birth, the suckling
activity is weak or absent and babies show little interest in feed-
ing during the first few months of their lives. After 2 years, it is
characterized by a true hyperphagia with obesity. In fact, PWS
children initially display anorexia as neonates and then switch to
hyperphagia with obesity (Tauber et al., 2014).
In parallel with the eating problem, PWS patients have mild
to moderate intellectual disability and behavioral alterations
(Ho and Dimitropoulos, 2010; Chevalere et al., 2013), includ-
ing emotional outbreaks (temper tantrums) and compulsive traits
(Dimitropoulos et al., 2006). Repetitive and ritualistic behaviors
and difficulty with routine changes (Holland et al., 2003; Greaves
et al., 2006; Dykens et al., 2011), similar to those found in autis-
tic spectrum conditions, have also been described. Indeed all
PW patients share some features of ASD (Koenig et al., 2004).
Some patients, who are diagnosed as autists, share some features
observed in PWS and are defined as PWS-like patients (Schaaf
et al., 2013).
Nevertheless, only a few patients with PWS are diagnosed as
autists. Patients with PWS present greater overall behavior dis-
turbance than age-matched mentally retarded patients, but score
comparably to patients with psychiatric disorders. Indeed, they
frequently display anxiety traits and anxious mood comparable
to those of patients presenting anxiety disorder or schizophre-
nia. They also show pronounced emotional liability and a striking
inability to control their emotions, which results in frequent emo-
tional outbreaks (temper tantrums), which can occur due to
an impaired capacity to understand the motivations of others
in the social environment, possibly indicating deficits in “the-
ory of mind” (the ability to attribute mental states to others)
and empathy (the ability to infer emotional experiences) (Lo
et al., 2013). Importantly, Tauber et al. (2011) reported the first
clinical trial on OT that showed that a single intranasal adminis-
tration of OT rescue some behavioral features, such as increased
trust and decreased signs of depression as well as emotional out-
breaks, in patients with PWS (Figure 5). However, a double-blind
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randomized cross-over trial of OT nasal spray performed in 22
PWS patients (12–29 years old) did not find statistically signif-
icant effects using 18–40 IU of intranasal OT twice daily for 8
weeks (Einfeld et al., 2014). The authors reported an increased
number of temper tantrums in the patients receiving the high
dose of OT and no effect was observed in patients treated with
low doses. The discrepancies between these two studies may be
explained by the dose used, the short wash-out period (15 days),
the duration of treatment and the sex ratio (most patients were
male in the report of Einfeld and colleagues compared to the
report of Tauber’s team).
Much of the phenotype of PWS is consistent with a hypotha-
lamic defect (Swaab et al., 1995; Swaab, 1997a,b) characterized by
a reduction of OT expressing neurons in the PVN, mostly repre-
sented by parvocellular OT neurons (Swaab et al., 1995; Swaab,
1997a,b). These cells project to the brainstem nuclei, including
the nucleus of the solitary tract, where OT acts as a powerful
anorexic peptide (Atasoy et al., 2012). Normal OT plasma lev-
els have been detected in 17 PWS adult patients (Höybye et al.,
2003), but elevated cerebrospinal fluid (CSF) OT levels have been
reported in five PWS patients (Martin et al., 1998). This high
level of OT in the CSF most likely relies on OT released from
magnocellular neurons, contacting both the vasculature of the
posterior pituitary and the lumen of the third ventricle (Knobloch
and Grinevich, 2014). However, such discrepancy between OT
released into the blood and CSF needs further clarification, espe-
cially with respect to methodological limitations for measuring
OT in biological samples (McCullough et al., 2013).
Genetically, PWS results from the lack of expression of sev-
eral contiguous imprinted genes located in the 15q11–q13 region.
These genes are regulated by genomic imprinting: a mechanism
leading to the transcriptional expression of the paternal alleles
of these genes only, the maternal alleles being silent (i.e., not
expressed). Recently, pathogenic mutations of MAGEL2 alone
have been reported in four patients (Schaaf et al., 2013), caus-
ing a classical PWS in one patient and PWS-like phenotypes in
the other three. All of the cases described were also diagnosed
with early feeding problems and ASD, without severe obesity.
These results underline MAGEL2’s contributing role in cogni-
tive and behavioral alterations in PWS and early feeding in
general.
Francoise Muscatelli’s group created a mouse model deficient
forMagel2. These mice showed an altered onset of suckling activ-
ity and subsequent impaired feeding leading to 50% of neonatal
lethality, affecting both males and females (Schaller et al., 2010).
Impressively, there is an obvious alteration of production of
mature OT in the PVN of Magel2-deficient pups, while a sin-
gle administration of OT, in a restricted time window after birth,
allows resetting of the feeding behavior and consequently rescues
the life of all pups (Schaller et al., 2010, p. 24). Furthermore, inac-
tivation of Magel2 induces in adult males (but not in females)
a deficit in social recognition and social interaction as well as
a reduced learning ability with an alteration of social and spa-
tial memory. A daily administration of oxytocin (OT) in the first
week of life is sufficient to restore suckling activity at birth and
to restore a normal social behavior and learning abilities in adult
mutant males (Meziane et al., in press).
Altogether, these results suggest that an alteration of the OT
system around birth has early and long term consequences on
feeding and social behaviors and on cognition. Importantly, an
OT treatment of Magel2-deficient pups in the first post-natal
week partially restores a normal anatomy of the OT system and
prevents deficits in social behavior and learning in adults. This
concept opens the door to a powerful pharmacological therapy
in early infancy for the PWS and might be considered for other
pathologies such as autism spectrum disorders. Importantly, a
clinical trial on OT treatment of PWS infants has been initiated
by Maithé Tauber and her team.
OT PATHWAYS IN PERINATAL ONTOGENESIS: PHYSIOLOGY,
PATHOLOGY, AND TREATMENT
While the picture of OT pathways development is far from
complete, at least three conclusions can be made (see Figure 6):
1) OT neurons start to produce a mature form of OT in
rodents much later than other neurons express AVP and
hypophyseotrophic neuropeptides (Markakis and Swanson,
1997; Markakis, 2002). In fact, in mice, the mature form of
OT appears on the day of delivery, suggesting that maternal
OT can promote synthesis of mature OT in newborns.
2) OT neurons (magnocellular) at birth have immature morpho-
logical (“spindle-like morphology”) and physiological prop-
erties (including intrinsic electrophysiological properties and
synaptic inputs). Furthermore, many OT neurons project
axons to the posterior pituitary only after birth (Makarenko
et al., 2002) and no collaterals of OT axons have been reported
in extrahypothalamic brain regions of neonates in contrast to
those in adult rodents (Knobloch and Grinevich, 2014).
3) OT receptors are widely expressed in the brain well before
the synthesis of mature OT, suggesting their receptivity either
for immature forms of OT, maternal OT, maternal/neonatal
AVP or uncharacterized peptides. During maturation of the
system (i.e., postweaning period > P60), the expression of
OTR is restricted to several brain regions, most of which are
innervated by OT axons at this age (Knobloch et al., 2012;
Dölen et al., 2013).
The delayed maturation of the central OT system in rodents (and
humans) may be caused or may correlate with the feature of
these species, which are born relatively immature (termed “altri-
cial” species). From a comparative point of view, it would be
interesting to compare the dynamics of OT system maturation
with the animals which are relatively mature and mobile from
the moment of birth (termed “precocial” species, such as guinea
pigs).
Since the distant/extrahypothalamic OT axons during neona-
tal period in studied (altricial) species are absent (at least not
reported), but OT neurons were responsive to externally applied
OT, it is most likely that neonate rodents operate by endogenous
OT released from somato-dendritic compartments of OT cells.
While PVN OT cells are closely located to the ependymal layer of
the third ventricle, OT may diffuse also to the cerebrospinal fluid,
resembling the evolutionarily old “transventricular” pathway of
OT action (Knobloch and Grinevich, 2014). Moreover, OT can
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FIGURE 6 | Central OT pathways in development. (A) The hypothalamus
of embryos produces immature OT. (B) After birth, the cells start to generate
mature (amidated) OT. Although it is unclear why this switch occurs, the fact
that it happens after parturition suggests that perinatal maternal OT (of
extremely high concentrations!), passing via the placental barrier (Malek
et al., 1996) to the hypothalamus of newborns, may initiate the activation
respective enzyme (see Figure 2) and, hence, appearance of the mature
form of OT. (C) After birth, the suckling activity of pups transmitted to the
activation of sensory pathways converging on OT neurons, may stimulate
somatodendritic OT release. Such mode of release leads to “ubiquitous
filling” of the brain with OT. (D) Later on, starting from the fourth week, OT
neurons establish axonal projections to various brain areas to release OT into
selective targets to modulate specific behaviors, especially social behaviors
(Knobloch and Grinevich, 2014).
reach the brain directly via brain capillaries, as the blood brain
barrier is not formed at that age (Ugrumov, 2010 and references
therein), allowing peripherally administered OT to efficiently
reach the brain (Meziane et al., in press).
In line with the “diffusion-like” mode of OT action, the
report on newborn and young mice (P0–P14; Zheng et al.,
2014) showed no axonal projections in the somatosensory cortex,
while the effects of OT on electrical activity of cortical neurons
as well as on sensory processing were very prominent (Zheng
et al., 2014). Keeping this contradiction in mind, the authors
speculated about “diffusible” OT reaching the cortex from the
hypothalamus. Despite the lack of literature, it is tempting to
speculate that magnocellular OT axons will grow to forebrain
regions and parvocellular OT neuronal axons to brain stem/spinal
cord only after weaning, to execute addressed OT release aimed to
orchestrate autonomic and behavioral responses respectively (see
above).
Animal models of social deficiency (such as OT and OTR
knockout mice) and human cases of OTR gene duplication
(Bittel et al., 2006) support the critical role of neonatal OT
signaling in the development of an adequate social skill. The
model of PWS—Magel2 knockout mice has pronounced OT
deficiency with delayed expression of mature OT on the day of
birth.
The discovery that peripheral OT administration to neonate
Magel2 knockout mice rescues both the feeding problem in
neonates and social impairments in adults, gives the reason to dis-
sect alteration in sequences of OT signaling (i.e., in steps of OT
expression in OT cells, OT transport via axons and their releas-
ing capacity, expression of OTR etc.), which can be considered
as target(s) for exogenous OT. Keeping in mind the potential OT
sensitivity of OT neurons, and many other brain cells, as well as
long-lasting OT effects, someonemay hypothesize that exogenous
OT stimulates transcriptional, electric and secretory activity of
OT neurons, which start to release larger amounts of OT to fill
in the brain. Additionally, upregulation of central OTR expression
can facilitate OT signaling. However, the testing of these scenarios
requires further comprehensive research.
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